Overview

Forced Fluid Removal in High Risk Acute Kidney Injury

Status:
Terminated
Trial end date:
2017-06-08
Target enrollment:
0
Participant gender:
All
Summary
The objective of this pilot trial is to assess the feasibility of forced fluid removal in patients admitted to the intensive care unit (ICU) with high-risk AKI and severe fluid overload. The intervention will use furosemide infusion and/or continuous renal replacement therapy (CRRT) to achieve and maintain a neutral cumulative fluid balance. The intervention will be compared to standard of care as reflected in the kidney disease improving global outcome (KDIGO) guidelines.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nordsjaellands Hospital
Collaborators:
Aalborg Universitetshospital
Aalborg University Hospital
Rigshospitalet, Denmark
Treatments:
Furosemide
Criteria
Inclusion Criteria:

- Age ≥ 18 years of age

- Acute Kidney Injury defined according to the KDIGO criteria

- Renal Recovery Score ≤ 60%. (Calculated using www.renal-recovery-score.com)

- Fluid overload defined as a positive fluid balance ≥ 10% of ideal body weight.

- Able to undergo randomization within 12 hours of fulfilling other inclusion criteria

Exclusion Criteria:

- Known pre-hospitalization advanced chronic kidney disease. (eGFR < 30 mL/minute/1.73
m2 or chronic RRT.)

- Severe hypoxic respiratory failure (use of invasive ventilation and FiO2 > 80% and
PEEP > 10 cm H2O)

- Severe burn injury (≥ 10% TBSA)

- Severe hypo- or hyper- natremia (< 120 or > 155 mmol/l)

- Hepatic coma

- Mentally disabled undergoing forced treatment

- Pregnancy/breast feeding

- Lack of commitment for on-going life support including RRT

- Lack of informed consent